Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,754
Closed -$427K 2364
2025
Q2
$427K Sell
14,754
-1,051
-7% -$29.8K ﹤0.01% 2501
2025
Q1
$454K Sell
15,805
-98
-0.6% -$3.7K ﹤0.01% 2511
2024
Q4
$712K Hold
15,903
﹤0.01% 2470
2024
Q3
$703K Sell
15,903
-2,393
-13% -$97.9K ﹤0.01% 2535
2024
Q2
$707K Buy
+18,296
New +$751K ﹤0.01% 2527
2022
Q2
Sell
-10,188
Closed -$527K 2710
2022
Q1
$527K Hold
10,188
﹤0.01% 2446
2021
Q4
$685K Buy
10,188
+988
+11% +$71.1K ﹤0.01% 2407
2021
Q3
$672K Hold
9,200
﹤0.01% 2357
2021
Q2
$545K Buy
9,200
+3,700
+67% +$189K ﹤0.01% 2505
2021
Q1
$236K Buy
+5,500
New +$272K ﹤0.01% 2535

Other funds holding DCBO

UBS AM's DCBO Position: Q3 2025 in Review

UBS AM sold out of Docebo (DCBO) in Q3 2025, closing a stake of 14,754 shares — an estimated $427K sold.

UBS AM first reported a position in DCBO in Q1 2021 and held it in 10 quarters. The position peaked at $712K in Q4 2024. 89 funds tracked by Wall St. Rank hold DCBO as of Q3 2025.

  • UBS AM reported no remaining Docebo position as of Q3 2025 after selling out during the quarter.
  • UBS AM sold 14,754 Docebo shares in Q3 2025, an estimated $427K.
  • UBS AM first reported a position in Docebo in Q1 2021 and held it in 10 quarters.
  • UBS AM's Docebo position peaked at $712K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held Docebo as of Q3 2025.

Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.